Knee Osteoarthritis Pain Relief Dimensions

Wilderman Medical Clinic is conducting a study to provide evidence of the validity of a new pain measurement tool. This tool will be used for the evaluation of the treatment effectiveness of corticosteroid injections for pain relief in patients with osteoarthritis of the knee. Osteoarthritis produces pain in the knee that is typically worsened by activities such as long distance walking. Corticosteroid injections into the knee joint are usually prescribed to treat the pain associated with osteoarthritis. 

There are currently no well-established tools that can accurately measure the percentage and duration of pain relief. The new, developed within Wilderman Medical Clinic, Integral of Pain Relief (IPR) is a pain measurement tool that assesses two significant pain relief dimensions: (1) the percentage of pain relief, and (2) the duration of pain relief. Both factors are reported by the patient and provide important information about whether and to what extent a treatment provides relief for patients.

Benefits to participate in the study:

  • Your medical condition will be closely monitored during study period.
  • You will receive an individual pain diary. Keeping this pain diary helps to improve overall pain management, allows the assessment of pain dynamics, and gives a better understanding of what works best to alleviate your pain.
  • Your family doctor will be updated in case of a change in your health condition.
  • Your participation with us will help to improve pain relief interventions and treatment plans for other patients with chronic pain conditions like osteoarthritis of the knee.

Preliminary eligibility criteria

  • You must be available to participate in this trial for up to 13 weeks.
  • You must be over the age of 40.
  • You must have a confirmed diagnosis of knee osteoarthritis and have knee pain more than 15 days in a month.
  • You must regularly receive corticosteroid injections or have considered receiving corticosteroid injections into the knee joint.

Further requirements will be reviewed with the doctor and trial personnel at the next stage and the evaluation.

To find out if you are eligible to participate in this study, please call (905) 886-1212 ext: 204 or e-mail [email protected]